Michael D Ezekowitz
Overview
Explore the profile of Michael D Ezekowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
186
Citations
21176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Vemulapalli S, Inohara T, Kim S, Thomas L, Piccini J, Patel M, et al.
Am J Cardiol
. 2019 Mar;
123(10):1628-1636.
PMID: 30846214
Systolic blood pressure (SBP) and its association with clinical outcomes in atrial fibrillation (AF) patients in community practice are poorly characterized. In patients with AF, we sought to (1) examine...
32.
January C, Samuel Wann L, Calkins H, Chen L, Cigarroa J, Cleveland Jr J, et al.
Heart Rhythm
. 2019 Feb;
16(8):e66-e93.
PMID: 30703530
No abstract available.
33.
January C, Samuel Wann L, Calkins H, Chen L, Cigarroa J, Cleveland Jr J, et al.
J Am Coll Cardiol
. 2019 Feb;
74(1):104-132.
PMID: 30703431
No abstract available.
34.
January C, Samuel Wann L, Calkins H, Chen L, Cigarroa J, Cleveland Jr J, et al.
Circulation
. 2019 Jan;
140(2):e125-e151.
PMID: 30686041
No abstract available.
35.
Hijazi Z, Verdecchia P, Oldgren J, Andersson U, Reboldi G, Di Pasquale G, et al.
J Am Heart Assoc
. 2019 Jan;
8(2):e010107.
PMID: 30651032
Background Cardiac biomarkers and left ventricular hypertrophy ( LVH ) are related to the risk of stroke and death in patients with atrial fibrillation. We investigated the interrelationship between LVH...
36.
Inohara T, Kim S, Pieper K, Blanco R, Allen L, Fonarow G, et al.
Heart
. 2018 Sep;
105(5):370-377.
PMID: 30228248
Objective: The association with B-type natriuretic peptide (BNP), disease progression and outcomes in patients with atrial fibrillation (AF) has not been thoroughly investigated. Methods: We evaluated the association between BNP...
37.
Jackson 2nd L, Kim S, Shrader P, Blanco R, Thomas L, Ezekowitz M, et al.
J Thromb Thrombolysis
. 2018 Jul;
46(4):435-439.
PMID: 30051164
Anticoagulation is highly effective for the prevention of stroke in patients with atrial fibrillation (AF) but it is dependent on patients continuing therapy. While studies have demonstrated suboptimal therapeutic persistence...
38.
Kent A, Brueckmann M, Fraessdorf M, Connolly S, Yusuf S, Eikelboom J, et al.
J Am Coll Cardiol
. 2018 Jul;
72(3):255-267.
PMID: 30012318
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used medications that can potentially increase the risk of bleeding and thrombosis. Objectives: This study quantified the effect of NSAIDs in the RE-LY...
39.
Goette A, Kwong W, Ezekowitz M, Banach M, Hjortshoj S, Zamoryakhin D, et al.
Europace
. 2018 Jun;
20(12):1936-1943.
PMID: 29947751
Aims: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) (NCT02072434) study was a multicentre prospective, randomized, open-label, blinded-endpoint evaluation (PROBE) trial comparing edoxaban with enoxaparin/warfarin followed...
40.
Ezekowitz M, Chandhok S, Arce J
JACC Clin Electrophysiol
. 2018 May;
3(12):1377-1379.
PMID: 29759667
No abstract available.